- Không có dữ liệu
Tiếng Việt
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
The R&D team of Xi'an Lixin Optoelectronics Technology Co., Ltd. (hereinafter referred to as "Lixin Optoelectronics") has made significant progress in 808nm high-power semiconductor laser chips through continuous technological breakthroughs.808nm semiconductor laser, as an ideal and efficient solid-state laser pump source, plays an important role in advanced manufacturing, mechanical processin...
On September 19th, Hongshan Laser made a stunning appearance at the Shanghai Industrial Expo with multiple flagship products. Among them, the "4+1" fully free heavy-duty groove laser pipe cutting machine TL730S, the 6G fully direct drive laser cutting machine G4020V, and the flagship drilling and attacking integrated laser composite pipe cutting machine TP65SD, represented by three new products, v...
Recently, an international research team led by Professor Zhang Peilei from the School of Materials Science and Engineering at Shanghai University of Engineering and Technology published a review paper titled "Research status of femtosecond lasers and nanosecond lasers processing on bulk metallic glasses (BMGs)" in the renowned journal Optics&Laser Technology in the field of optics and lasers....
Nikon Vision, a subsidiary of Nikon Corporation, is pleased to announce the launch of the COOLSHOT 20i GIII laser rangefinder for golfers, which is Nikon's small and lightweight model in the COOLSHOT series.While maintaining the lightweight and compact size of the COOLSHOT 20i GII, the new model notifies users through brief vibrations that the distance to the flagpole has been measured.When measur...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...